EIC ACCESS+ Funded GLP Tox Services

This service can be EIC Acess + funded up to 60k. Apply here

This service offers regulatory toxicology studies in compliance with Good Laboratory Practice (GLP) to support the development of drugs, medical devices, and chemical products. The service duration varies depending on the complexity of the required studies, ranging from a few weeks to 12 months. It is targeted at pharmaceutical and biotech companies, as well as research and development institutions. The goal of the service is to provide reliable toxicological data accepted by regulatory authorities, essential for the submission of new drugs or product applications. The studies cover different phases, from preclinical characterization to safety assessment, with activities including in vitro and in vivo testing, single and repeated dose studies, and target organ toxicity evaluation. Expected outcomes include complete toxicology reports, ready for regulatory submission, ensuring compliance with international requirements. The process is carried out by an internal team of experts with extensive experience in GLP studies, guaranteeing the highest quality and scientific rigor at every stage.